BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30922557)

  • 1. Larger oocyte cohorts maximize fresh IVF cycle birth rates and availability of surplus high-quality blastocysts for cryopreservation.
    Connell MT; Richter KS; Devine K; Hill MJ; DeCherney AH; Doyle JO; Tucker MJ; Levy MJ
    Reprod Biomed Online; 2019 May; 38(5):711-723. PubMed ID: 30922557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The number of oocytes retrieved during IVF: a balance between efficacy and safety.
    Magnusson Å; Källen K; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2018 Jan; 33(1):58-64. PubMed ID: 29136154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oocyte or embryo number needed to optimize live birth and cumulative live birth rates in mild stimulation IVF cycles.
    Datta AK; Campbell S; Felix N; Singh JSH; Nargund G
    Reprod Biomed Online; 2021 Aug; 43(2):223-232. PubMed ID: 34140227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian stimulation for freeze-all IVF cycles: a systematic review.
    Mizrachi Y; Horowitz E; Farhi J; Raziel A; Weissman A
    Hum Reprod Update; 2020 Jan; 26(1):118-135. PubMed ID: 31867625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: a retrospective cohort study.
    Chen YH; Xu XH; Wang Q; Zhang SD; Jiang LL; Zhang CL; Ge ZJ
    J Assist Reprod Genet; 2015 Oct; 32(10):1459-67. PubMed ID: 26384107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between the number of oocytes retrieved for IVF, perinatal outcome and obstetric complications.
    Magnusson Å; Wennerholm UB; Källén K; Petzold M; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2018 Oct; 33(10):1939-1947. PubMed ID: 30124838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles.
    Steward RG; Lan L; Shah AA; Yeh JS; Price TM; Goldfarb JM; Muasher SJ
    Fertil Steril; 2014 Apr; 101(4):967-73. PubMed ID: 24462057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; van Wely M
    Cochrane Database Syst Rev; 2010 Nov; (11):CD008046. PubMed ID: 21069701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive outcomes after a single dose of gonadotropin-releasing hormone agonist compared with human chorionic gonadotropin for the induction of final oocyte maturation in hyper-responder women aged 35-40 years.
    Tannus S; Turki R; Cohen Y; Son WY; Shavit T; Dahan MH
    Fertil Steril; 2017 Jun; 107(6):1323-1328.e2. PubMed ID: 28501366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oocyte donor stimulation on recipient outcomes: data from a US national donor oocyte bank.
    Hipp HS; Gaskins AJ; Nagy ZP; Capelouto SM; Shapiro DB; Spencer JB
    Hum Reprod; 2020 Apr; 35(4):847-858. PubMed ID: 32142582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.
    Lainas GT; Kolibianakis EM; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas TG; Tarlatzis BC
    Hum Reprod; 2013 Jul; 28(7):1929-42. PubMed ID: 23624582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the number of oocytes retrieved and cumulative live birth rate in women aged 35-40 years undergoing long GnRH agonist IVF/ICSI cycles.
    Zhou J; Wang B; Hu Y; Sun H
    Arch Gynecol Obstet; 2017 Nov; 296(5):1005-1012. PubMed ID: 28879481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equivalent live-birth rate in antagonist IVF/ICSI protocol after oocyte triggering with GnRH agonist supplemented with 1500 r-hCG the day of oocyte retrieval vs r-hCG : A case-control study.
    Cherrière F; Arvis P; Le Pabic E; Bidet M; Jaffré F; Guivarc'h-Levêque A
    J Gynecol Obstet Hum Reprod; 2020 Jun; 49(6):101702. PubMed ID: 32018042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of GnRH-a prolonged protocol for in vitro fertilization in 18,272 cycles in China.
    Tian L; Xia L; Wu Q
    J Ovarian Res; 2022 Oct; 15(1):110. PubMed ID: 36209186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of GnRH-agonist trigger for the final maturation of oocytes in normal and low responders undergoing planned oocyte cryopreservation.
    Maslow BL; Guarnaccia M; Stefanacci C; Ramirez L; Klein JU
    Hum Reprod; 2020 May; 35(5):1054-1060. PubMed ID: 32406915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].
    Wu CX; Zhang T; Shu L; Huang J; Diao FY; Ding W; Gao Y; Wang W; Mao YD; Cui YG; Liu JY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):160-166. PubMed ID: 29609229
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.